MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

Atara Biotherapeutics Inc

Closed

SectorHealthcare

9.81 1.76

Overview

Share price change

24h

Current

Min

9.55

Max

10.68

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+70% upside

Dividends

By Dow Jones

Next Earnings

8 sie 2025

News Sentiment

By Acuity

25%

75%

54 / 376 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

Atara Biotherapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

7 mar 2025, 21:54 UTC

Earnings

Atara Biotherapeutics to Cut Half of Workforce Amid Restructuring

16 sty 2025, 16:17 UTC

Major Market Movers

Atara Shares Sink After FDA Stalls Cancer Treatment

16 sty 2025, 14:31 UTC

Major Market Movers

FDA Rejects Atara's Request to Bring Blood Cancer Treatment to Market

Peer Comparison

Price change

Atara Biotherapeutics Inc Forecast

Price Target

By TipRanks

70% upside

12 Months Forecast

Average 17 USD  70%

High 17 USD

Low 17 USD

Based on 1 Wall Street analysts offering 12 month price targets forAtara Biotherapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

7.245 / 7.64Support & Resistance

Short Term

Weak Bearish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

54 / 376 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

$